Literature DB >> 12503609

Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms.

Marie-Gabrielle Ludwig1, Klaus Seuwen.   

Abstract

The membrane-bound adenylyl cyclases (ACs) represent one of the major families of effector enzymes for G protein-coupled receptors. Eight human AC isoforms, encoded by separate genes, have been identified up to now. However, in several cases only partial cDNA sequences are available (ADCY1,2,5). A ninth expected isoform, the human ortholog of rat ADCY4, has not been described yet. Using the high inter-species homology of mammalian AC isoforms, we searched the human genome and we succeeded to identify full-length coding sequences for all enzymes. Where required, missing sequence information was provided experimentally. Analysis of genomic sequences from the Celera database also allowed us to determine the exon-intron boundaries for ADCY1-9 and to establish the gene structures. We found that human AC genes comprise 11 to 26 exons, which are distributed over 16 to 430kb. We further report expression profiles for the nine ACs in a panel of 16 human tissues and in human embryonic kidney (HEK) cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503609     DOI: 10.1081/rrs-120014589

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  42 in total

1.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

Review 2.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

Review 3.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 4.  Alveolar epithelial beta2-adrenergic receptors.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

5.  TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.

Authors:  Jeongmin Song; Brian L Bishop; Guojie Li; Matthew J Duncan; Soman N Abraham
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

6.  A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Authors:  Monica Soto-Velasquez; Michael P Hayes; Aktan Alpsoy; Emily C Dykhuizen; Val J Watts
Journal:  Mol Pharmacol       Date:  2018-06-27       Impact factor: 4.436

7.  Genome-wide study of families with absolute pitch reveals linkage to 8q24.21 and locus heterogeneity.

Authors:  Elizabeth Theusch; Analabha Basu; Jane Gitschier
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

8.  Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.

Authors:  Svetlana Puzhko; Cynthia Gates Goodyer; Mohammad Amin Kerachian; Lucie Canaff; Madhusmita Misra; Harald Jüppner; Murat Bastepe; Geoffrey N Hendy
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

9.  Activator of G protein signaling 3 forms a complex with resistance to inhibitors of cholinesterase-8A without promoting nucleotide exchange on Gα(i3).

Authors:  Man K Tse; Christina J Morris; Mingjie Zhang; Yung H Wong
Journal:  Mol Cell Biochem       Date:  2014-12-06       Impact factor: 3.396

10.  Contributions of specificity protein-1 and steroidogenic factor 1 to Adcy4 expression in Y1 mouse adrenal cells.

Authors:  Xianliang Rui; Jennivine Tsao; Joshua O Scheys; Gary D Hammer; Bernard P Schimmer
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.